BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30271202)

  • 1. Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy.
    Tang X; Xu Y; Lu L; Jiao Y; Liu J; Wang L; Zhao H
    Cancer Manag Res; 2018; 10():3533-3549. PubMed ID: 30271202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis.
    Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
    Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the exocytosis pathway genes in cervical cancer.
    Eswaran S; Adiga D; Khan G N; S S; Kabekkodu SP
    Am J Med Sci; 2022 Jun; 363(6):526-537. PubMed ID: 34995576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
    Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
    Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis.
    Wu K; Yi Y; Liu F; Wu W; Chen Y; Zhang W
    Oncol Lett; 2018 Jul; 16(1):1003-1009. PubMed ID: 29963176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data.
    Li C; Wan Y; Deng W; Fei F; Wang L; Qi F; Zheng Z
    Open Med (Wars); 2022; 17(1):96-112. PubMed ID: 35028418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis.
    Wu X; Peng L; Zhang Y; Chen S; Lei Q; Li G; Zhang C
    Int J Med Sci; 2019; 16(6):800-812. PubMed ID: 31337953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
    Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
    Front Genet; 2020; 11():530892. PubMed ID: 33061942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key genes and small molecule drugs in osteoarthritis by integrated bioinformatics analysis.
    Liu Z; Wang H; Cheng X; Zhang J; Gao Y
    Biochem Biophys Rep; 2023 Jul; 34():101450. PubMed ID: 36923006
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Xia L; Su X; Shen J; Meng Q; Yan J; Zhang C; Chen Y; Wang H; Xu M
    Cancer Manag Res; 2018; 10():663-670. PubMed ID: 29670400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of crucial aberrantly methylated and differentially expressed genes related to cervical cancer using an integrated bioinformatics analysis.
    Ma X; Liu J; Wang H; Jiang Y; Wan Y; Xia Y; Cheng W
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32368784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCNA in Cervical Intraepithelial Neoplasia and Cervical Cancer: An Interaction Network Analysis of Differentially Expressed Genes.
    Giannos P; Kechagias KS; Bowden S; Tabassum N; Paraskevaidi M; Kyrgiou M
    Front Oncol; 2021; 11():779042. PubMed ID: 34900731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate biomarkers correlated with the diagnosis and prognosis of cervical cancer via integrated bioinformatics analysis.
    Dai F; Chen G; Wang Y; Zhang L; Long Y; Yuan M; Yang D; Liu S; Cheng Y; Zhang L
    Onco Targets Ther; 2019; 12():4517-4532. PubMed ID: 31354287
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
    Luo B; Gu YY; Wang XD; Chen G; Peng ZG
    Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.